AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64%

4DX 4DMedical Limited

Healthcare · Medical Devices · website · 124 employees
$3.96
52wk 0.30 – 7.55
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About 4DMedical Limited

4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$2.37B
P/E (trailing)
P/E (forward)
-61.87
EPS (trailing)
-0.40
Dividend yield
Payout ratio
0.0%
Beta
1.97
EV / EBITDA
-37.53
Price / Book
-74.72
ROE
-1,099.3%
Operating margin
-929.7%
Net margin
0.0%
Total cash
$56.76M
Total debt
$10.24M
Current ratio
6.58
Debt / Equity
Free cash flow
$-117.52M
Avg volume
7.15M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$5.78M
  • Gross profit$5.31M
  • Operating income-$47.57M
  • Net income-$30.07M
  • Diluted EPS-0.14
  • Free cash flow-$34.76M
  • Net debt-$2.57M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9